InsidersTradesSigma
Track the 삼양바이오팜 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 삼양바이오팜 has logged 10 public disclosures. Market capitalisation: €397.8bn. The latest transaction was filed on 19 March 2026 (Other). Among the most active insiders: 김윤. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
Samyang Biopharm is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.